Volume 41 Issue 1
Jan.  2020
Turn off MathJax
Article Contents
Ran Wang, Fu-Jia Yang, Xiao-Yan Zheng, Xian-Zheng Liao, Dong-Ying Fan, Hui Chen, Jing An. Long-term protection against dengue viruses in mice conferred by a tetravalent DNA vaccine candidate. Zoological Research, 2020, 41(1): 90-93. doi: 10.24272/j.issn.2095-8137.2020.016
Citation: Ran Wang, Fu-Jia Yang, Xiao-Yan Zheng, Xian-Zheng Liao, Dong-Ying Fan, Hui Chen, Jing An. Long-term protection against dengue viruses in mice conferred by a tetravalent DNA vaccine candidate. Zoological Research, 2020, 41(1): 90-93. doi: 10.24272/j.issn.2095-8137.2020.016

Long-term protection against dengue viruses in mice conferred by a tetravalent DNA vaccine candidate

doi: 10.24272/j.issn.2095-8137.2020.016
#Authors contributed equally to this work
Funds:  This work was supported by the National Natural Science Foundation of China (81772172; 81671971; U1602223)
More Information
  • #Authors contributed equally to this work
  • loading
  • [1]
    Babiuk S, Tsang C, van Drunen Littel-van den Hurk S, Babiuk LA, Griebel PJ. 2007. A single hbsag DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. Bioelectrochemistry, 70(2): 269−274. doi: 10.1016/j.bioelechem.2006.10.003
    [2]
    Chen H, Zheng X, Wang R, Gao N, Sheng Z, Fan D, Feng K, Liao X, An J. 2016. Immunization with electroporation enhances the protective effect of a DNA vaccine candidate expressing prme antigen against dengue virus serotype 2 infection. Clinical Immunology, 171: 41−49. doi: 10.1016/j.clim.2016.08.021
    [3]
    Davis HL, Schirmbeck R, Reimann J, Whalen RG. 1995. DNA-mediated immunization in mice induces a potent mhc class i-restricted cytotoxic t lymphocyte response to the hepatitis b envelope protein. Human Gene Therapy, 6(11): 1447−1456. doi: 10.1089/hum.1995.6.11-1447
    [4]
    Fatima K, Syed NI. 2018. Dengvaxia controversy: Impact on vaccine hesitancy. Journal of Global Health, 8(2): 010312. doi: 10.7189/jogh.08.020312
    [5]
    Fynan EF, Lu S, Robinson HL. 2018. One group's historical reflections on DNA vaccine development. Human Gene Therapy, 29(9): 966−970. doi: 10.1089/hum.2018.066
    [6]
    Gurunathan S, Prussin C, Sacks DL, Seder RA. 1998. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nature Medicine, 4(12): 1409−1415. doi: 10.1038/4000
    [7]
    Kudlacek ST, Metz SW. 2019. Focused dengue vaccine development: outwitting nature's design. Pathogens and Disease, 77(1): ftz003. doi: 10.1093/femspd/ftz003
    [8]
    Lee JS, Lourenco J, Gupta S, Farlow A. 2018. A multi-country study of dengue vaccination strategies with dengvaxia and a future vaccine candidate in three dengue-endemic countries: vietnam, thailand, and colombia. Vaccine, 36(17): 2346−2355. doi: 10.1016/j.vaccine.2018.03.002
    [9]
    Li L, Petrovsky N. 2016. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Review Vaccines, 15(3): 313−329. doi: 10.1586/14760584.2016.1124762
    [10]
    Prompetchara E, Ketloy C, Thomas SJ, Ruxrungtham K. 2019. Dengue vaccine: global development update. Asian Pacific Journal of Allergy and Immunology. doi: 10.12932/AP-100518-0309
    [11]
    Reich NG, Shrestha S, King AA, Rohani P, Lessler J, Kalayanarooj S, Yoon IK, Gibbons RV, Burke DS, Cummings DA. 2013. Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. Journal of the Royal Society Interface, 10(86): 20130414. doi: 10.1098/rsif.2013.0414
    [12]
    Sheng Z, Chen H, Feng K, Gao N, Wang R, Wang P, Fan D, An J. 2019. Electroporation-mediated immunization of a candidate DNA vaccine expressing dengue virus serotype 4 prm-e antigen confers long-term protection in mice. Virologica Sinica, 34(1): 88−96. doi: 10.1007/s12250-019-00090-8
    [13]
    Sheng Z, Gao N, Cui X, Fan D, Chen H, Wu N, Wei J, An J. 2016. Electroporation enhances protective immune response of a DNA vaccine against japanese encephalitis in mice and pigs. Vaccine, 34(47): 5751−5757. doi: 10.1016/j.vaccine.2016.10.001
    [14]
    Shrivastava A, Tripathi NK, Dash PK, Parida M. 2017. Working towards dengue as a vaccine-preventable disease: challenges and opportunities. Expert Opinion Biological Therapy, 17(10): 1193−1199. doi: 10.1080/14712598.2017.1356284
    [15]
    Wang R, Liao X, Fan D, Wang L, Song J, Feng K, Li M, Wang P, Chen H, An J. 2018. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal zika virus infection in immunocompetent balb/c mice. Vaccine, 36(24): 3522−3532. doi: 10.1016/j.vaccine.2018.04.051
    [16]
    Wang R, Zheng X, Sun J, Feng K, Gao N, Fan D, Chen H, Jin X, An J. 2019. Vaccination with a single consensus envelope protein ectodomain sequence administered in a heterologous regimen induces tetravalent immune responses and protection against dengue viruses in mice. Frontiers in Microbiology, 10: 1113. doi: 10.3389/fmicb.2019.01113
    [17]
    Wilder-Smith A, Ooi EE, Horstick O, Wills B. 2019. Dengue. The Lancet, 393: 350−363. doi: 10.1016/S0140-6736(18)32560-1
    [18]
    Zhang ZS, Weng YW, Huang HL, Zhang JM, Yan YS. 2015. Neutralizing antibodies respond to a bivalent dengue DNA vaccine or/and a recombinant bivalent antigen. Molecular Medicine Reports, 11(2): 1009−1016. doi: 10.3892/mmr.2014.2850
    [19]
    Zheng X, Chen H, Wang R, Fan D, Feng K, Gao N, An J. 2017. Effective protection induced by a monovalent DNA vaccine against dengue virus (dv) serotype 1 and a bivalent DNA vaccine against dv1 and dv2 in mice. Fronties in Cellular and Infection Microbiology, 7: 175. doi: 10.3389/fcimb.2017.00175
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (2345) PDF downloads(728) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return